Shabana Mahmood's potential move to Chancellor is underway, concurrent with Jonathan Reynolds being likely appointed Business Secretary under Andy Burnham, all against a backdrop of market shifts affecting AstraZeneca.
1 report, 1 independent
Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Shabana Mahmood's potential move to Chancellor is underway, concurrent with Jonathan Reynolds being likely appointed Business Secretary under Andy Burnham, all against a backdrop of market shifts affecting AstraZeneca.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Shabana Mahmood
British politician (born 1980)
-
Jonathan Reynolds
British politician (born 1980)
-
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.
- Geopolitical instability in the Middle East has led to significant corporate fallout, including the cancellation of Flutter's London Stock Exchange listing and AstraZeneca considering a move to the US market.